Effects of CD34 + cell dose on haematopoietic recovery in acute lymphoblastic leukaemia patients with positive pretransplant measurable residual disease.

Yuewen WangXiaodong MoYifei ChengYuhong ChenMeng LvFengrong WangChenhua YanWei HanHuan ChenLanping XuYu WangXiaohui ZhangXin-Xin LiuXiaojun HuangYing-Jun Chang

Published in: International journal of laboratory hematology (2022)

stem and progenitor cell harvests were needed to ensure successful haematopoietic recovery in pre-HSCT MRD-positive patients compared to pre-HSCT MRD-negative patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
bone marrow
intensive care unit
cell therapy
mesenchymal stem cells
patient reported